1.61 USD
↘ 0.03 (1.83%)AT CLOSE (11:59 AM EDT)
60 Degrees Pharmaceuticals, Inc. Common Stock
SXTPNASDAQ • USD
1.62
↗ 0.01 (0.62%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
1.62
↗ 0.01 (0.62%)
Market: CLOSED
Shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) are trading at $1.61. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 26, 2026.
Open?$1.64
High?$1.66
Low?$1.60
Prev. Close?$1.64
Volume?32.4K
Avg. Volume?106.3K
VWAP?$1.65
Rel. Volume?0.31x
Bid / Ask
Bid?$1.37 × 100
Ask?$1.89 × 100
Spread?$0.52
Midpoint?$1.63
Valuation & Ratios
Market Cap?4.3M
Shares Out?2.7M
Float?2.6M
Float %?98.3%
P/E Ratio?N/A
P/B Ratio?0.89
EPS?-$3.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Employees
3
Market Cap
4.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-07-12
Address
1025 CONNECTICUT AVENUE NW
WASHINGTON, DC 20036
Phone: 202-327-5422
WASHINGTON, DC 20036
Phone: 202-327-5422
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?77
Short Sent.?71
Piotroski F-Score?2/9Weak
Altman Z-Score?-11.98Distress
Confidence?48%Low
Short InterestElevated
Short % of Float?5.81%Elevated
Short Interest?150.7K
Days to Cover?1.0
Free Float2.6M
Avg Daily Volume165.5K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.34Strong
Quick Ratio?2.85Strong
Cash Ratio?1.78Strong
Debt/Equity?0.03Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.89CHEAP▾
Peers100
S&P97
P/S?3.26FAIR▾
Peers100
S&P47
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?0.83CHEAP▾
Peers100
S&P94
Returns & Efficiency
ROE?-167.0%WEAK▾
S&P3
ROA?-119.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-8160418
Enterprise Value?$1.1M
Fundamentals ratios updated end of day